Akzo Nobel India Limited (AKZOINDIA) - Net Assets
Based on the latest financial reports, Akzo Nobel India Limited (AKZOINDIA) has net assets worth Rs22.55 Billion INR (≈ $243.91 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs36.51 Billion ≈ $394.80 Million USD) and total liabilities (Rs13.95 Billion ≈ $150.89 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Akzo Nobel India Limited liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs22.55 Billion |
| % of Total Assets | 61.78% |
| Annual Growth Rate | 6.1% |
| 5-Year Change | 3.25% |
| 10-Year Change | 82.47% |
| Growth Volatility | 18.01 |
Akzo Nobel India Limited - Net Assets Trend (1998–2025)
This chart illustrates how Akzo Nobel India Limited's net assets have evolved over time, based on quarterly financial data. Also explore Akzo Nobel India Limited balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for Akzo Nobel India Limited (1998–2025)
The table below shows the annual net assets of Akzo Nobel India Limited from 1998 to 2025. For live valuation and market cap data, see market cap of Akzo Nobel India Limited.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs13.30 Billion ≈ $143.86 Million |
+0.02% |
| 2024-03-31 | Rs13.30 Billion ≈ $143.82 Million |
+1.03% |
| 2023-03-31 | Rs13.16 Billion ≈ $142.35 Million |
+4.51% |
| 2022-03-31 | Rs12.60 Billion ≈ $136.21 Million |
-2.24% |
| 2021-03-31 | Rs12.88 Billion ≈ $139.32 Million |
+4.06% |
| 2020-03-31 | Rs12.38 Billion ≈ $133.89 Million |
+8.95% |
| 2019-03-31 | Rs11.36 Billion ≈ $122.89 Million |
-11.98% |
| 2018-03-31 | Rs12.91 Billion ≈ $139.61 Million |
+27.86% |
| 2017-03-31 | Rs10.10 Billion ≈ $109.18 Million |
+38.49% |
| 2016-03-31 | Rs7.29 Billion ≈ $78.84 Million |
-20.76% |
| 2015-03-31 | Rs9.20 Billion ≈ $99.49 Million |
+8.52% |
| 2014-03-31 | Rs8.48 Billion ≈ $91.69 Million |
-23.30% |
| 2013-03-31 | Rs11.05 Billion ≈ $119.53 Million |
-23.30% |
| 2012-03-31 | Rs14.41 Billion ≈ $155.84 Million |
+32.01% |
| 2011-03-31 | Rs10.92 Billion ≈ $118.05 Million |
+10.03% |
| 2010-03-31 | Rs9.92 Billion ≈ $107.29 Million |
+2.16% |
| 2009-03-31 | Rs9.71 Billion ≈ $105.02 Million |
+27.17% |
| 2008-03-31 | Rs7.64 Billion ≈ $82.58 Million |
-12.29% |
| 2007-03-31 | Rs8.71 Billion ≈ $94.15 Million |
+42.95% |
| 2006-03-31 | Rs6.09 Billion ≈ $65.86 Million |
+4.26% |
| 2005-03-31 | Rs5.84 Billion ≈ $63.17 Million |
+2.97% |
| 2004-03-31 | Rs5.67 Billion ≈ $61.35 Million |
-5.19% |
| 2003-03-31 | Rs5.98 Billion ≈ $64.71 Million |
+11.23% |
| 2002-03-31 | Rs5.38 Billion ≈ $58.17 Million |
+41.27% |
| 2001-03-31 | Rs3.81 Billion ≈ $41.18 Million |
+12.93% |
| 2000-03-31 | Rs3.37 Billion ≈ $36.47 Million |
+10.68% |
| 1999-03-31 | Rs3.05 Billion ≈ $32.95 Million |
+13.28% |
| 1998-03-31 | Rs2.69 Billion ≈ $29.08 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Akzo Nobel India Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 813.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs7.75 Billion | 58.25% |
| Common Stock | Rs455.00 Million | 3.42% |
| Other Comprehensive Income | Rs5.10 Billion | 38.33% |
| Total Equity | Rs13.30 Billion | 100.00% |
Akzo Nobel India Limited Competitors by Market Cap
The table below lists competitors of Akzo Nobel India Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Telecom Argentina SA ADR
NYSE:TEO
|
$1.45 Billion |
|
Elite Semiconductor Memory Technology Inc
TW:3006
|
$1.45 Billion |
|
Jinzhou Jixiang Molybdenum Co Ltd
SHG:603399
|
$1.45 Billion |
|
Sansure Biotech Inc
SHG:688289
|
$1.45 Billion |
|
Three's Company Media Group Co Ltd
SHG:605168
|
$1.45 Billion |
|
Longkou Union Chemical Co. Ltd. A
SHE:301209
|
$1.45 Billion |
|
Eyebright Medical Technology Beijing Co Ltd
SHG:688050
|
$1.45 Billion |
|
Nektar Therapeutics
NASDAQ:NKTR
|
$1.45 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Akzo Nobel India Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 13,299,000,000 to 13,302,000,000, a change of 3,000,000 (0.0%).
- Net income of 4,295,000,000 contributed positively to equity growth.
- Dividend payments of 4,326,000,000 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs4.29 Billion | +32.29% |
| Dividends Paid | Rs4.33 Billion | -32.52% |
| Other Changes | Rs34.00 Million | +0.26% |
| Total Change | Rs- | 0.02% |
Book Value vs Market Value Analysis
This analysis compares Akzo Nobel India Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 10.10x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 44.69x to 10.10x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-03-31 | Rs66.03 | Rs2950.70 | x |
| 1999-03-31 | Rs74.45 | Rs2950.70 | x |
| 2000-03-31 | Rs82.50 | Rs2950.70 | x |
| 2001-03-31 | Rs93.17 | Rs2950.70 | x |
| 2002-03-31 | Rs107.74 | Rs2950.70 | x |
| 2003-03-31 | Rs121.76 | Rs2950.70 | x |
| 2004-03-31 | Rs125.04 | Rs2950.70 | x |
| 2005-03-31 | Rs127.59 | Rs2950.70 | x |
| 2006-03-31 | Rs132.73 | Rs2950.70 | x |
| 2007-03-31 | Rs212.81 | Rs2950.70 | x |
| 2008-03-31 | Rs192.01 | Rs2950.70 | x |
| 2009-03-31 | Rs253.90 | Rs2950.70 | x |
| 2010-03-31 | Rs265.23 | Rs2950.70 | x |
| 2011-03-31 | Rs296.35 | Rs2950.70 | x |
| 2012-03-31 | Rs300.46 | Rs2950.70 | x |
| 2013-03-31 | Rs234.80 | Rs2950.70 | x |
| 2014-03-31 | Rs181.70 | Rs2950.70 | x |
| 2015-03-31 | Rs197.17 | Rs2950.70 | x |
| 2016-03-31 | Rs156.24 | Rs2950.70 | x |
| 2017-03-31 | Rs216.37 | Rs2950.70 | x |
| 2018-03-31 | Rs276.66 | Rs2950.70 | x |
| 2019-03-31 | Rs247.50 | Rs2950.70 | x |
| 2020-03-31 | Rs271.85 | Rs2950.70 | x |
| 2021-03-31 | Rs282.89 | Rs2950.70 | x |
| 2022-03-31 | Rs276.57 | Rs2950.70 | x |
| 2023-03-31 | Rs289.04 | Rs2950.70 | x |
| 2024-03-31 | Rs292.03 | Rs2950.70 | x |
| 2025-03-31 | Rs292.09 | Rs2950.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Akzo Nobel India Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 32.29%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.50%
- • Asset Turnover: 1.41x
- • Equity Multiplier: 2.18x
- Recent ROE (32.29%) is above the historical average (21.73%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | 18.78% | 8.15% | 0.91x | 2.53x | Rs236.13 Million |
| 1999 | 20.15% | 8.41% | 1.02x | 2.34x | Rs309.14 Million |
| 2000 | 19.03% | 8.27% | 1.20x | 1.92x | Rs304.31 Million |
| 2001 | 22.83% | 11.89% | 1.08x | 1.78x | Rs488.41 Million |
| 2002 | 18.53% | 8.91% | 0.98x | 2.13x | Rs375.34 Million |
| 2003 | 21.12% | 11.82% | 0.87x | 2.06x | Rs553.65 Million |
| 2004 | 20.76% | 12.02% | 0.88x | 1.96x | Rs549.96 Million |
| 2005 | 10.55% | 6.38% | 0.89x | 1.85x | Rs28.43 Million |
| 2006 | 9.75% | 5.33% | 1.02x | 1.80x | Rs-13.66 Million |
| 2007 | 53.21% | 45.59% | 0.77x | 1.51x | Rs3.76 Billion |
| 2008 | 7.86% | 6.38% | 0.81x | 1.52x | Rs-163.54 Million |
| 2009 | 30.34% | 32.73% | 0.68x | 1.37x | Rs1.97 Billion |
| 2010 | 16.06% | 16.97% | 0.68x | 1.38x | Rs600.90 Million |
| 2011 | 16.18% | 16.24% | 0.71x | 1.41x | Rs674.40 Million |
| 2012 | 14.00% | 10.25% | 0.89x | 1.53x | Rs577.00 Million |
| 2013 | 19.80% | 9.89% | 0.96x | 2.09x | Rs1.08 Billion |
| 2014 | 17.72% | 6.26% | 1.18x | 2.40x | Rs654.20 Million |
| 2015 | 20.25% | 7.44% | 1.39x | 1.96x | Rs943.00 Million |
| 2016 | 29.38% | 8.19% | 1.30x | 2.77x | Rs1.41 Billion |
| 2017 | 24.47% | 9.60% | 1.37x | 1.87x | Rs1.46 Billion |
| 2018 | 30.99% | 14.82% | 1.21x | 1.73x | Rs2.71 Billion |
| 2019 | 18.57% | 7.29% | 1.38x | 1.85x | Rs973.70 Million |
| 2020 | 19.18% | 9.00% | 1.13x | 1.88x | Rs1.14 Billion |
| 2021 | 16.11% | 8.66% | 0.95x | 1.96x | Rs787.70 Million |
| 2022 | 23.03% | 9.33% | 1.20x | 2.06x | Rs1.64 Billion |
| 2023 | 25.46% | 8.87% | 1.38x | 2.08x | Rs2.03 Billion |
| 2024 | 32.08% | 10.84% | 1.36x | 2.18x | Rs2.94 Billion |
| 2025 | 32.29% | 10.50% | 1.41x | 2.18x | Rs2.96 Billion |
Industry Comparison
This section compares Akzo Nobel India Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $4,640,465,518
- Average return on equity (ROE) among peers: 19.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Akzo Nobel India Limited (AKZOINDIA) | Rs22.55 Billion | 18.78% | 0.62x | $1.45 Billion |
| Aarti Industries Limited (AARTIIND) | $5.93 Billion | 17.40% | 1.80x | $1.99 Billion |
| Aarti Surfactants Limited (AARTISURF) | $1.68 Billion | 7.56% | 1.39x | $37.34 Million |
| ABM International Limited (ABMINTLLTD) | $161.33 Million | 4.08% | 2.02x | $4.23 Million |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $1.71 Billion | 11.54% | 1.37x | $420.87 Million |
| Aether Industries Limited (AETHER) | $782.77 Million | 51.04% | 2.84x | $1.68 Billion |
| Alkali Metals Limited (ALKALI) | $658.97 Million | 9.93% | 0.56x | $7.38 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $5.37 Billion | 40.12% | 0.46x | $838.56 Million |
| Ami Organics Limited (AMIORG) | $389.92 Million | 30.90% | 1.80x | $1.18 Billion |
| Anupam Rasayan India Limited (ANURAS) | $25.08 Billion | 7.21% | 0.51x | $1.65 Billion |
About Akzo Nobel India Limited
Akzo Nobel India Limited manufactures, distributes, and sells paints and coatings in India and internationally. It offers paints, enamels or lacquers, and varnishes for interior, exterior, waterproofing, and woodcare and metal applications; waterproofing paint products; weathershield paint for institutions/builders/contractors; and automotive and specialty, industrial, powder, and marine and prot… Read more